Circulating immune complexes (CICs) isolated from sera of patients with IgA nephropathy (IgAN) consist of undergalactosylated, mostly polymeric, and J chain–containing IgA1 and IgG antibodies specific for N-acetylgalactosamine (GalNAc) residues in O-linked glycans of the hinge region of IgA1 heavy chains. Antibodies with such specificity occur in sera of IgAN patients, and in smaller quantities in patients with non-IgA proliferative glomerulonephritis and in healthy controls; they are present mainly in the IgG (predominantly IgG2 subclass), and less frequently in the IgA1 isotype. Their specificity for GalNAc was determined by reactivity with IgA1 myeloma proteins with enzymatically removed N-acetylneuraminic acid (NeuNAc) and galactose (Gal); removal of the O-linked glycans of IgA1 resulted in significantly decreased reactivity. Furthermore, IgA2 proteins that lack the hinge region with O-linked glycans but are otherwise structurally similar to IgA1 did not react with IgG or IgA1 antibodies. The re-formation of isolated and acid-dissociated CICs was inhibited more effectively by IgA1 lacking NeuNAc and Gal than by intact IgA1. Immobilized GalNAc and asialo-ovine submaxillary mucin (rich in O-linked glycans) were also effective inhibitors. Our results suggest that the deficiency of Gal in the hinge region of IgA1 molecules results in the generation of antigenic determinants containing GalNAc residues that are recognized by naturally occurring IgG and IgA1 antibodies.
Milan Tomana, Jan Novak, Bruce A. Julian, Karel Matousovic, Karel Konecny, Jiri Mestecky
Title and authors | Publication | Year |
---|---|---|
Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy
Sindhuri Prakash, Nicholas Steers, Yifu Li, Elena Sanchez-Rodriguez, Miguel Verbitsky, Isabel Robbins, Jenna Simpson, Sharvari Pathak, Milan Raska, Colin Reily, Anna Ng, Judy Liang, Natalia DeMaria, Amanda Katiraei, Kelsey Stevens, Clara Fischman, Samantha Shapiro, Swetha Kodali, Jason McCutchan, Heekuk Park, Djamila Eliby, Marco Delsante, Landino Allegri, Enrico Fiaccadori, Monica Bodria, Maddalena Marasa, Elizabeth Raveche, Bruce A. Julian, Anne-Catrin Uhlemann, Krzysztof Kiryluk, Hong Zhang, Vivette D'Agati, Simone Sanna-Cherchi, Jan Novak, Ali Gharavi |
Journal of Clinical Investigation | 2025 |
Exploring the causal role of pathogen-derived antibodies in major urinary and kidney diseases: Insights from generalized summary data-based Mendelian randomization
Huang H, Chen B, Feng C, Chen W, Wu D |
Virulence | 2025 |
Recent Progress in Developing Extracellular Vesicles as Nanovehicles to Deliver Carbohydrate-Based Therapeutics and Vaccines
Puagsopa J, Tongviseskul N, Jaroentomeechai T, Meksiriporn B |
Vaccines | 2025 |
Emerging biochemical and immunological mechanisms in the pathogenesis of IgA nephropathy
Novak J, Reily C, Steers NJ, Schumann T, Rizk DV, Julian BA, Kiryluk K, Gharavi AG, Green TJ |
Seminars in nephrology | 2025 |
Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide
Keskinis C, Moysidou E, Stai S, Christodoulou M, Lioulios G, Vamvakas SS, Trivyza MS, Pateinakis P, Papasotiriou M, Stangou M |
Medicina | 2025 |
Recent advances in pathogenetic concepts and disease modeling of IgA nephropathy
Dreher L, Nilges L, Wiech T, Rinschen MM, Tomas NM |
Clinical Kidney Journal | 2025 |
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies.
Cheung CK, Barratt J, Liew A, Zhang H, Tesar V, Lafayette R |
2024 | |
Insights on Nefecon(®), a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy.
Barratt J, Kristensen J, Pedersen C, Jerling M |
Drug design, development and therapy | 2024 |
The Expression of Non B Cell-Derived Immunoglobulins.
Zheng J, Li G, Liu W, Deng Y, Xu X |
Advances in experimental medicine and biology | 2024 |
IgA Nephropathy: Significance of IgA1-Containing Immune Complexes in Clinical Settings
Suzuki H, Novak J |
Journal of Clinical Medicine | 2024 |
Intestinal epithelium dysfunctions cause IgA deposition in the kidney glomeruli of intestine-specific Ap1m2-deficient mice
Kinashi Y, Tanaka K, Kimura S, Hirota M, Komiyama S, Shindo T, Hashiguchi A, Takahashi D, Shibata S, Karaki SI, Ohno H, Hase K |
eBioMedicine | 2024 |
Contemporary review of IgA nephropathy
Filippone EJ, Gulati R, Farber JL |
Frontiers in Immunology | 2024 |
Causal association between peripheral immune cells and IgA nephropathy: a Mendelian randomization study
Liang LM, Xiong L, He XL, Song LJ, Wang X, Lu YZ, Ye H, Ma WL, Yu F |
Frontiers in Immunology | 2024 |
The pathogenesis of IgA nephropathy and implications for treatment.
Cheung CK, Alexander S, Reich HN, Selvaskandan H, Zhang H, Barratt J |
Nature reviews. Nephrology | 2024 |
Pathogenic Immunoglobulin A-Producing Cells in Immunoglobulin A Nephropathy
Makita Y, Reich HN |
Journal of Clinical Medicine | 2024 |
O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy
Novak J, King RG, Yother J, Renfrow MB, Green TJ |
Glycobiology | 2024 |
Pathogenesis of IgA Nephropathy: Omics Data Inform Glycomedicine
Novak J |
Nephrology (Carlton, Vic.) | 2024 |
Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan
Aoki R, Nihei Y, Matsuzaki K, Suzuki H, Kihara M, Ogawa A, Nishino T, Sanada S, Yokote S, Okabe M, Shirai S, Fukuda A, Hoshino J, Kondo D, Yokoo T, Kashihara N, Narita I, Suzuki Y |
Kidney360 | 2024 |
My Lifetime in IgA Nephropathy: An Unexpected Journey
Julian BA |
Nephrology (Carlton, Vic.) | 2024 |
Exploring the mediating role of immune cells in the pathogenesis of IgA nephropathy through the inflammatory axis of gut microbiota from a genomic perspective.
Huang H, Chen B, Feng C, Chen W, Wu D |
Mammalian genome : official journal of the International Mammalian Genome Society | 2024 |
Lessons from IgA Nephropathy Models
Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M, Lee M, Aoki R, Yamada K, Muto M, Suzuki Y |
International Journal of Molecular Sciences | 2024 |
Immunoglobulin A Antibodies: From Protection to Harmful Roles
Gleeson PJ, Camara NO, Launay P, Lehuen A, Monteiro RC |
Immunological Reviews | 2024 |
What is new in the pathogenesis and treatment of IgA glomerulonephritis
Salvadori M, Rosso G |
World Journal of Nephrology | 2024 |
Roles of Streptococcus mutans in human health: beyond dental caries
Fang Y, Chen X, Chu CH, Yu OY, He J, Li M |
Frontiers in Microbiology | 2024 |
IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease
Mestecky J, Julian BA, Raska M |
Frontiers in immunology | 2023 |
Omics are Getting Us Closer to Understanding IgA Nephropathy.
Mucha K, Pac M, Pączek L |
Archivum Immunologiae et Therapiae Experimentalis | 2023 |
Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
Nihei Y, Suzuki H, Suzuki Y |
Frontiers in immunology | 2023 |
GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy
Jemelkova J, Stuchlova Horynova M, Kosztyu P, Zachova K, Zadrazil J, Galuszkova D, Takahashi K, Novak J, Raska M |
Kidney International Reports | 2023 |
Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-κB signaling pathway.
Xu W, Song W, Chen S, Jin S, Xue X, Min J, Wang X, You P |
Frontiers in pharmacology | 2023 |
IgA nephropathy associated with Crohn's disease
Tamura H |
World Journal of Methodology | 2023 |
The Effects of Perilla frutescens Extracts on IgA Nephropathy: A Systematic Review and Meta-Analysis
Adam G, Adam AM, Robu S, Harabor V, Harabor A, Nechita A, Marin DB, Morariu ID, Cioanca O, Vasilache IA, Hancianu M |
Pharmaceuticals | 2023 |
[Diagnosis and Treatment of IgA Nephropathy-2023].
Schimpf J, Kronbichler A, Windpessl M, Zitt E, Eller K, Säemann MD, Lhotta K, Rudnicki M |
Wiener klinische Wochenschrift | 2023 |
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.
Rajasekaran A, Green TJ, Renfrow MB, Julian BA, Novak J, Rizk DV |
Drugs | 2023 |
The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies
Tang Z, Yu S, Pan Y |
Journal of Translational Medicine | 2023 |
IgA nephropathy.
Stamellou E, Seikrit C, Tang SCW, Boor P, Tesař V, Floege J, Barratt J, Kramann R |
Nature Reviews Disease Primers | 2023 |
Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with Oxford MEST-C Scores
Rizk DV, Novak L, Hall SD, Moldoveanu Z, Julian BA, Novak J, Haas M |
Journal of Clinical Medicine | 2023 |
Differentiating primary and secondary FSGS using non-invasive urine biomarkers.
Catanese L, Siwy J, Wendt R, Amann K, Beige J, Hendry B, Mischak H, Mullen W, Paterson I, Schiffer M, Wolf M, Rupprecht H |
Clinical Kidney Journal | 2023 |
Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease.
Tumoglu B, Keelaghan A, Avci FY |
Glycobiology | 2023 |
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG |
The New England journal of medicine | 2023 |
New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid
D Lin, C Chang, Y Hsu, C Lin |
International journal of molecular sciences | 2022 |
Development and Evaluation of a Robust Sandwich Immunoassay System Detecting Serum WFA-Reactive IgA1 for Diagnosis of IgA Nephropathy
Uenoyama Y, Matsuda A, Ohashi K, Ueda K, Yokoyama M, Kyoutou T, Kishi K, Takahama Y, Nagai M, Ohbayashi T, Hotta O, Matsuzaki H |
International journal of molecular sciences | 2022 |
Sialylation as an Important Regulator of Antibody Function
Vattepu R, Sneed SL, Anthony RM |
Frontiers in immunology | 2022 |
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors
Zachova K, Jemelkova J, Kosztyu P, Ohyama Y, Takahashi K, Zadrazil J, Orsag J, Matousovic K, Galuszkova D, Petejova N, Mestecky J, Raska M |
Journal of the American Society of Nephrology : JASN | 2022 |
Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy
Person T, King RG, Rizk DV, Novak J, Green TJ, Reily C |
Journal of Interferon & Cytokine Research | 2022 |
The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy
Sanchez-Russo L, Rajasekaran A, Bin S, Faith J, Cravedi P |
2022 | |
IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers
Xu L, Li Y, Wu X |
Frontiers in immunology | 2022 |
Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
Ohyama Y, Yamaguchi H, Ogata S, Chiurlia S, Cox SN, Kouri NM, Stangou MJ, Nakajima K, Hayashi H, Inaguma D, Hasegawa M, Yuzawa Y, Tsuboi N, Renfrow MB, Novak J, Papagianni AA, Schena FP, Takahashi K |
iScience | 2022 |
Clinical phenotype and cytokine profile of adult IgA vasculitis with joint involvement.
Delapierre A, Terrier B, Pillebout E, Baudart P, Jourde-Chiche N, Lioger B, Martis N, Moulis G, Rivière E, Le Gouellec N, Raffray L, Urbanski G, Sanges S, Maurier F, Deroux A, Mekinian A, Monteiro R, Marcelli C, Guillevin L, Maillot F, Lucas B, Aouba A, Audemard-Verger A |
Clinical Rheumatology | 2022 |
Crohn's disease may promote inflammation in IgA nephropathy: a case-control study of patients undergoing kidney biopsy.
Akiyama M, Shimomura K, Yoshimoto H, Sako M, Kodama M, Abe K, Gunji M, Kang D, Takaki T, Wada Y, Iyoda M, Honda K |
Virchows Archiv : an international journal of pathology | 2022 |
Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion.
Zhu X, Shen X, Lin B, Fang J, Jin J, He Q |
Frontiers in pharmacology | 2022 |
Increased retinal drusen in IgA glomerulonephritis are further evidence for complement activation in disease pathogenesis.
Harraka P, Wightman T, Akom S, Sandhu K, Colville D, Catran A, Langsford D, Pianta T, Barit D, Ierino F, Skene A, Mack H, Savige J |
Scientific Reports | 2022 |
Identification and characterization of circulating immune complexes in IgA nephropathy.
Matsumoto Y, Aryal RP, Heimburg-Molinaro J, Park SS, Wever WJ, Lehoux S, Stavenhagen K, van Wijk JAE, Van Die I, Chapman AB, Chaikof EL, Cummings RD |
Science Advances | 2022 |
Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
Reily C, Rice T, Crossman DK, Rizk DV |
Journal of Autoimmunity | 2022 |
Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation
Luvizotto MJ, Menezes-Silva L, Woronik V, Monteiro RC, Câmara NO |
Frontiers in Cell and Developmental Biology | 2022 |
Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy
Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M, Lee M, Kato R, Aoki R, Yamada K, Muto M, Suzuki Y |
Biomedicines | 2022 |
Emerging Roles of the Unique Molecular Chaperone Cosmc in the Regulation of Health and Disease.
Xiang T, Qiao M, Xie J, Li Z, Xie H |
Biomolecules | 2022 |
Metabolic signatures of immune cells in chronic kidney disease
Li J, Yang Y, Wang Y, Li Q, He F |
Expert Reviews in Molecular Medicine | 2022 |
Low-molecular weight inhibitors of the alternative complement pathway.
Schubart A, Flohr S, Junt T, Eder J |
Immunological Reviews | 2022 |
Propensity of Immunoglobulin A Self-aggregation via ‘Tailpiece’ Cysteine-471 and Treatment of IgA Nephropathy Using Cysteamine
Xinfang Xie, Li Gao, Pan Liu, Jicheng Lv, Wan-Hong Lu, Hong Zhang, Jing Jin |
JCI Insight | 2021 |
Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy
H Zeng, L Wang, J Li, S Luo, Q Han, F Su, J Wei, X Wei, J Wu, B Li, J Huang, P Tang, C Cao, Y Zhou, Q Yang |
Cell & Bioscience | 2021 |
Antibody Glycosylation
M Pezer |
2021 | |
Antibody Glycosylation
M Pezer |
2021 | |
Antibody Glycosylation
M Pezer |
2021 | |
Antibody Glycosylation
M Pezer |
2021 | |
Antibody Glycosylation
M Pezer |
2021 | |
Antibody Glycosylation
M Pezer |
2021 | |
Antibody Glycosylation
M Pezer |
2021 | |
Antibody Glycosylation
M Pezer |
2021 | |
Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics
Tilo Freiwald, Behdad Afzali |
Advances in immunology | 2021 |
Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune Diseases
A Bordron, M Morel, C Bagacean, M Dueymes, P Pochard, A Harduin-Lepers, C Jamin, JO Pers |
International journal of molecular sciences | 2021 |
Fantastic IgA plasma cells and where to find them
B Isho, A Florescu, AA Wang, JL Gommerman |
Immunological Reviews | 2021 |
Renal deposition and clearance of recombinant poly‐ IgA complexes in a model of IgA nephropathy
X Xie, P Liu, L Gao, X Zhang, P Lan, V Bijol, J Lv, H Zhang, J Jin |
The Journal of Pathology | 2021 |
Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
Y Ohyama, MB Renfrow, J Novak, K Takahashi |
Journal of Clinical Medicine | 2021 |
Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment
B Knoppova, C Reily, RG King, BA Julian, J Novak, TJ Green |
Journal of Clinical Medicine | 2021 |
IgA glycosylation and immune complex formation in IgAN
H Suzuki, J Novak |
Seminars in Immunopathology | 2021 |
IgA Vasculitis with Nephritis in Adults: Histological and Clinical Assessment
L Lai, S Liu, M Azrad, S Hall, C Hao, J Novak, BA Julian, L Novak |
Journal of Clinical Medicine | 2021 |
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy
Z Moldoveanu, H Suzuki, C Reily, K Satake, L Novak, N Xu, ZQ Huang, B Knoppova, A Khan, S Hall, H Yanagawa, R Brown, CJ Winstead, DB O'Quinn, A Weinmann, AG Gharavi, K Kiryluk, BA Julian, CT Weaver, Y Suzuki, J Novak |
Journal of Autoimmunity | 2021 |
IgA vasculitis with nephritis: update of pathogenesis with clinical implications
MC Hastings, DV Rizk, K Kiryluk, R Nelson, RS Zahr, J Novak, RJ Wyatt |
Pediatric Nephrology | 2021 |
Comparative Long-Term Renal Allograft Outcomes of Recurrent Immunoglobulin A with Severe Activity in Kidney Transplant Recipients with and without Rituximab: An Observational Cohort Study
W Chancharoenthana, A Leelahavanichkul, W Ariyanon, S Vadcharavivad, W Phumratanaprapin |
Journal of Clinical Medicine | 2021 |
Pathogenesis of IgA Vasculitis: An Up-To-Date Review
Y Song, X Huang, G Yu, J Qiao, J Cheng, J Wu, J Chen |
Frontiers in immunology | 2021 |
Immunoglobulin A, an Active Liaison for Host-Microbiota Homeostasis
AA Abokor, GH McDaniel, RM Golonka, C Campbell, S Brahmandam, BS Yeoh, B Joe, M Vijay-Kumar, P Saha |
Microorganisms | 2021 |
The microbiome and IgA nephropathy
K Haniuda, JL Gommerman, HN Reich |
Seminars in Immunopathology | 2021 |
Poly-IgA Complexes and Disease Severity in IgA Nephropathy
X Zhang, J Lv, P Liu, X Xie, M Wang, D Liu, H Zhang, J Jin |
Clinical journal of the American Society of Nephrology : CJASN | 2021 |
Cosmc deficiency causes spontaneous autoimmunity by breaking B cell tolerance
J Zeng, RP Aryal, K Stavenhagen, C Luo, R Liu, X Wang, J Chen, H Li, Y Matsumoto, Y Wang, J Wang, T Ju, RD Cummings |
Science Advances | 2021 |
Immune Characteristics of IgA Nephropathy With Minimal Change Disease.
Li H, Lu W, Li H, Liu X, Zhang X, Xie L, Lan P, Yu X, Dai Y, Xie X, Lv J |
Frontiers in pharmacology | 2021 |
The immune landscape of IgA induction in the gut
C Seikrit, O Pabst |
Seminars in Immunopathology | 2021 |
Is complement the main accomplice in IgA nephropathy? From initial observations to potential complement-targeted therapies
MB Stang, PJ Gleeson, MR Daha, RC Monteiro, C van Kooten |
Molecular Immunology | 2021 |
A Fresh Perspective on Monoclonal Gammopathies of Renal Significance
P Aucouturier, VD DAgati, P Ronco |
Kidney International Reports | 2021 |
PATHOLOGY AND RENAL OUTCOME OF THREE UNCOMMON FACES OF CRESCENTRIC GLOMERULONEPHRITIS
K Basu, D Sircar, M Bandopadhyay |
2021 | |
Systolic blood pressure and chronic kidney disease progression in patients with primary glomerular disease
HW Kim, JT Park, YS Joo, SC Kang, JY Lee, S Lee, TI Chang, EW Kang, DR Ryu, TH Yoo, HJ Chin, SW Kang, SH Han |
Journal of Nephrology | 2021 |
Streptococcus mutans induces IgA nephropathy-like glomerulonephritis in rats with severe dental caries
S Naka, K Wato, T Misaki, S Ito, D Matsuoka, Y Nagasawa, R Nomura, M Matsumoto-Nakano, K Nakano |
Scientific Reports | 2021 |
IgA Nephropathy that Developed as an Immune-related Adverse Event of Pembrolizumab Complicated with Interstitial Nephritis.
Mitarai Y, Nakashima K, Fukunaga S, Ishikawa N, Ito T, Tsubata Y, Isobe T |
Internal Medicine | 2021 |
Proceedings of 16th International Symposium on IgA Nephropathy
|
Kidney Diseases | 2021 |
Erythrocytosis associated with IgA nephropathy
Cohen C, Coulon S, Bhukhai K, Neuraz A, Dussiot M, Fouquet G, Stang MB, Flamant M, Vrtovsnik F, Hummel A, Knebelmann B, Mesnard L, Rondeau E, Maciel TT, Favale F, Casadevall N, Nguyen-Khoa T, Moutereau S, Legendre C, Benhamou M, Monteiro RC, Hermine O, El Karoui K, Moura IC |
EBioMedicine | 2021 |
Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
K Zachova, P Kosztyu, J Zadrazil, K Matousovic, K Vondrak, P Hubacek, BA Julian, Z Moldoveanu, Z Novak, K Kostovcikova, M Raska, J Mestecky |
Frontiers in immunology | 2020 |
The Role of Immune Modulation in Pathogenesis of IgA Nephropathy
S Chang, XK Li |
Frontiers in Medicine | 2020 |
Quantitative assessment of successive carbohydrate additions to the clustered O -glycosylation sites of IgA1 by glycosyltransferases
TJ Stewart, K Takahashi, N Xu, A Prakash, R Brown, M Raska, MB Renfrow, J Novak |
Glycobiology | 2020 |
Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival
M Eder, N Kozakowski, H Omic, C Aigner, J Kläger, B Perschl, R Reindl-Schwaighofer, G Bond, GA Böhmig, Ž Kikić |
Journal of Nephrology | 2020 |
CDR3 sequences in IgA nephropathy are shorter and exhibit reduced diversity
, J Zeng, Y Tong, L Zhang, X Lu, S Zhu, Z Li |
FEBS Open Bio | 2020 |
IgG deposits in the mesangium and capillary loops predict poor renal outcome in patients with IgA nephropathy: a single-center retrospective study
S Peng, W Lu, X Jiang, X Xu, Y Wu |
Renal Failure | 2020 |
Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives
T Gan, Y Li, X Zhou, H Zhang |
International journal of biological sciences | 2020 |
Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers
C Jacobs-Cachá, A Vergara, C García-Carro, I Agraz, N Toapanta-Gaibor, G Ariceta, F Moreso, D Serón, J López-Hellín, MJ Soler |
Clinical Kidney Journal | 2020 |
Emerging Modes of Treatment of IgA Nephropathy
D Maixnerova, V Tesar |
International journal of molecular sciences | 2020 |
The analysis of treatment of Immunoglobulin A-nephropathy
VA Dobronravov, ZS Kochoyan, TO Muzhetskaya, DI Lin |
2020 | |
Simultaneous Immunoglobulin A and G Glycopeptide Profiling for High-Throughput Applications
A Momčilović, N de Haan, AL Ederveen, A Bondt, CA Koeleman, D Falck, LA de Neef, WE Mesker, R Tollenaar, A de Ru, P van Veelen, M Wuhrer, V Dotz |
Analytical Chemistry | 2020 |
Role of CD8+ T cells in crescentic glomerulonephritis
A Chen, K Lee, T Guan, JC He, D Schlondorff |
Nephrology Dialysis Transplantation | 2019 |
A New Vision of IgA Nephropathy: The Missing Link
F Sallustio, C Curci, VD Leo, A Gallone, F Pesce, L Gesualdo |
International journal of molecular sciences | 2019 |
The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
DV Rizk, N Maillard, BA Julian, B Knoppova, TJ Green, J Novak, RJ Wyatt |
Frontiers in immunology | 2019 |
IgA1 hinge-region clustered glycan fidelity is established early during semi-ordered glycosylation by GalNAc-T2
TJ Stewart, K Takahashi, RH Whitaker, M Raska, WJ Placzek, J Novak, MB Renfrow |
Glycobiology | 2019 |
Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy
G Li, X Wang, Z Yang, Q Zhao, Y Wen, X Li, R Gao |
Disease Markers | 2019 |
Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation
B Wehbi, C Oblet, F Boyer, A Huard, A Druilhe, F Paraf, E Cogné, J Moreau, YE Makhour, B Badran, MV Egmond, M Cogné, JC Aldigier |
Journal of the American Society of Nephrology : JASN | 2019 |
A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy
Y Ouyang, L Zhu, M Shi, S Yu, Y Jin, Z Wang, J Ma, M Yang, X Zhang, X Pan, H Ren, W Wang, H Zhang, J Xie, N Chen |
Frontiers in immunology | 2019 |
Association between anti-α-1,4-D-polygalacturonic acid antibodies and Henoch-Schönlein purpura in children
M Miao, X Li, Q Wang, Y Zhu, Y Cui, X Shao |
J INT MED RES | 2019 |
The role of complement in IgA nephropathy
A Tortajada, E Gutierrez, MC Pickering, MP Terente, N Medjeral-Thomas |
Molecular Immunology | 2019 |
Serum IgA1 shows increased levels of α 2,6-linked sialic acid in breast cancer
HJ Lomax-Browne, C Robertson, A Antonopoulos, AJ Leathem, SM Haslam, A Dell, MV Dwek |
Interface Focus | 2019 |
Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study
S Bagchi, R Lingaiah, K Mani, A Barwad, G Singh, V Balooni, D Bhowmik, SK Agarwal, T Shimosawa |
PloS one | 2019 |
Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy
D Liu, J You, Y Liu, X Tang, X Tan, M Xia, L Wu, G Chen, L He, X Zhu, H Liu |
International Immunopharmacology | 2019 |
Approach to the Child with Hematuria
DD Brown, KJ Reidy |
Pediatric Clinics of North America | 2019 |
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy
JR Myette, T Kano, H Suzuki, SE Sloan, KJ Szretter, B Ramakrishnan, H Adari, KD Deotale, F Engler, Z Shriver, A Wollacott, Y Suzuki, BJ Pereira |
Kidney International | 2019 |
Immunoglobulin A-nephropathy in Russian population: clinical and morphological presentation and long-term prognosis
VA Dobronravov, TO Muzhetskaya, DI Lin, ZS Kochoyan |
2019 | |
The Potential Clinical Significance of the Biomarker IgA1
T Robert |
Kidney International Reports | 2019 |
Murine Models of Human IgA Nephropathy
H Suzuki, Y Suzuki |
Seminars in Nephrology | 2018 |
Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
WJ Placzek, H Yanagawa, Y Makita, MB Renfrow, BA Julian, DV Rizk, Y Suzuki, J Novak, H Suzuki, IC Moura |
PloS one | 2018 |
The Emerging Role of Pathogenesis of IgA Nephropathy
MY Wu, CS Chen, GT Yiang, PW Cheng, YL Chen, HC Chiu, KH Liu, WC Lee, CJ Li |
Journal of Clinical Medicine | 2018 |
Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy
J Novak, J Barratt, BA Julian, MB Renfrow |
Seminars in Nephrology | 2018 |
Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients
C Reily, DV Rizk, BA Julian, J Novak |
BioTechniques | 2018 |
Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy
C Nguyen, K König, FW Tam, H Hopfer, K Molyneux, FI Binet, MJ Kim |
Clinical Kidney Journal | 2018 |
Recent advances in the physiopathology of IgA nephropathy
RC Monteiro |
Néphrologie & Thérapeutique | 2018 |
Genetic Determinants of IgA Nephropathy: Western Perspective
YD Neugut, K Kiryluk |
Seminars in Nephrology | 2018 |
Effector and regulatory B cells in immune-mediated kidney disease
K Oleinika, C Mauri, A Salama |
Nature Reviews Nephrology | 2018 |
15th International Symposium on IgANephropathy - IIgANN 2018, Buenos Aires, September 27-29, 2018: Summaries
|
Kidney Diseases | 2018 |
Campylobacter rectus in the Oral Cavity Correlates with Proteinuria in Immunoglobulin A Nephropathy Patients
T Misaki, S Naka, K Wato, R Hatakeyama, Y Nagasawa, S Ito, H Inaba, R Nomura, M Matsumoto-Nakano, K Nakano |
Nephron. Clinical practice | 2018 |
Biomarkers and Precision Medicine in IgA Nephropathy
FP Schena, SN Cox |
Seminars in Nephrology | 2018 |
Expression of immunoglobulin A in human mesangial cells and its effects on cell apoptosis and adhesion
H Deng, J Ma, Z Jing, Z Deng, Y Liang, L A, Y Liu, X Qiu, Y Wang |
Molecular medicine reports | 2018 |
IgA nephropathy in a patient with IgG Myeloma
BS Lakshmi, SV Devi, NS Sameera, AS Reddy, R Ram, VS Kumar |
Indian journal of nephrology | 2018 |
Effector and regulatory B cells in immune-mediated kidney disease
K Oleinika, C Mauri, AD Salama |
Nature Reviews Nephrology | 2018 |
Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice
JM Chemouny, PJ Gleeson, L Abbad, G Lauriero, E Boedec, KL Roux, C Monot, M Bredel, J Bex-Coudrat, A Sannier, E Daugas, F Vrtovsnik, L Gesualdo, M Leclerc, L Berthelot, SB Mkaddem, P Lepage, RC Monteiro |
Nephrology Dialysis Transplantation | 2018 |
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
K Yamada, ZQ Huang, M Raska, C Reily, JC Anderson, H Suzuki, H Ueda, Z Moldoveanu, K Kiryluk, Y Suzuki, RJ Wyatt, Y Tomino, AG Gharavi, A Weinmann, BA Julian, CD Willey, J Novak |
Kidney International Reports | 2017 |
Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome
F Candotti |
Journal of Clinical Immunology | 2017 |
What Genetics Tells Us About the Pathogenesis of IgA Nephropathy: The Role of Immune Factors and Infection
YM Zhang, XJ Zhou, H Zhang |
Kidney International Reports | 2017 |
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway
K Kiryluk, Y Li, Z Moldoveanu, H Suzuki, C Reily, P Hou, J Xie, N Mladkova, S Prakash, C Fischman, S Shapiro, RA LeDesma, D Bradbury, I Ionita-Laza, F Eitner, T Rauen, N Maillard, F Berthoux, J Floege, N Chen, H Zhang, F Scolari, RJ Wyatt, BA Julian, AG Gharavi, J Novak, AJ Myers |
PLoS genetics | 2017 |
Inflammation in IgA nephropathy
T Rauen, J Floege |
Pediatric Nephrology | 2017 |
Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy
AS Alvarado, NK Andeen, S Brodsky, A Hinton, T Nadasdy, CE Alpers, C Blosser, B Najafian, BH Rovin |
Nephrology Dialysis Transplantation | 2017 |
Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy: Altered glycosylation of IgG complexes in RA
J Stümer, MH Biermann, J Knopf, I Magorivska, A Kastbom, A Svärd, C Janko, R Bilyy, G Schett, C Sjöwall, M Herrmann, LE Muñoz |
Clinical & Experimental Immunology | 2017 |
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
BC Fellström, J Barratt, H Cook, R Coppo, J Feehally, JW de Fijter, J Floege, G Hetzel, AG Jardine, F Locatelli, BD Maes, A Mercer, F Ortiz, M Praga, SS Sørensen, V Tesar, LD Vecchio |
The Lancet | 2017 |
Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis
M Krochmal, K Cisek, S Filip, K Markoska, C Orange, J Zoidakis, C Gakiopoulou, G Spasovski, H Mischak, C Delles, A Vlahou, J Jankowski |
Scientific Reports | 2017 |
Epitope mapping of a new anti-Tn antibody detecting gastric cancer cells
N Persson, N Stuhr-Hansen, C Risinger, S Mereiter, A Polónia, K Polom, A Kovács, F Roviello, CA Reis, C Welinder, L Danielsson, B Jansson, O Blixt |
Glycobiology | 2017 |
What insights can proteomics give us into IgA nephropathy (Berger’s disease)?
MB Renfrow, J Novak |
Expert Review of Proteomics | 2017 |
Wisteria floribunda agglutinin positive glycobiomarkers: a unique lectin as a serum biomarker probe in various diseases
H Narimatsu, T Sato |
Expert Review of Proteomics | 2017 |
Is there a role for immunosuppression in immunoglobulin A nephropathy?
AI Al-Lawati, HN Reich |
Nephrology Dialysis Transplantation | 2017 |
Progrès récents dans la maladie de Berger (néphropathie à dépôts d’IgA)
RC Monteiro |
Bulletin de l'Académie nationale de médecine | 2017 |
IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition
Z Oruc, C Oblet, A Boumediene, A Druilhe, V Pascal, EL Rumeur, A Cuvillier, CE Hamel, S Lecardeur, T Leanderson, W Morelle, J Demengeot, JC Aldigier, M Cogne |
Journal of the American Society of Nephrology : JASN | 2016 |
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
B Knoppova, C Reily, N Maillard, DV Rizk, Z Moldoveanu, J Mestecky, M Raska, MB Renfrow, BA Julian, J Novak |
Frontiers in immunology | 2016 |
IgA nephropathy enigma
J Mestecky, J Novak, Z Moldoveanu, M Raska |
Clinical Immunology | 2016 |
Immunoglobulin A nephropathy: a pathophysiology view
RC Fabiano, SV Pinheiro, AC Silva |
Inflammation Research | 2016 |
Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy
ZQ Huang, M Raska, TJ Stewart, C Reily, RG King, DK Crossman, MR Crowley, A Hargett, Z Zhang, H Suzuki, S Hall, RJ Wyatt, BA Julian, MB Renfrow, AG Gharavi, J Novak |
Journal of the American Society of Nephrology : JASN | 2016 |
Markers for the progression of IgA nephropathy
D Maixnerova, C Reily, Q Bian, M Neprasova, J Novak, V Tesar |
Journal of Nephrology | 2016 |
Glyco-engineering for the production of recombinant IgA1 with distinct mucin-type O-glycans in plants
M Dicker, D Maresch, R Strasser |
Bioengineered | 2016 |
IgA1 Glycosylation Is Heritable in Healthy Twins
HJ Lomax-Browne, A Visconti, CD Pusey, HT Cook, TD Spector, MC Pickering, M Falchi |
Journal of the American Society of Nephrology : JASN | 2016 |
Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
MJ Kim, S Schaub, K Molyneux, MT Koller, S Stampf, J Barratt, X Zhou |
PloS one | 2016 |
A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer
L Cornelissen, SV Vliet |
Biomolecules | 2016 |
Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins--What Determines the Site of Injury?
M Doshi, A Lahoti, FR Danesh, V Batuman, PW Sanders |
Clinical journal of the American Society of Nephrology : CJASN | 2016 |
IgA nephropathy
KN Lai, SC Tang, FP Schena, J Novak, Y Tomino, AB Fogo, RJ Glassock |
Nature Reviews Disease Primers | 2016 |
Glycobiology and Human Diseases
YP Lin, M Osburne, M Pereira, J Coburn, J Leong |
Glycobiology and Human Diseases | 2016 |
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
K Ebefors, P Liu, E Lassén, J Elvin, E Candemark, K Levan, B Haraldsson, J Nyström |
BMC Nephrology | 2016 |
Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro
Q Dai, J Liu, Y Du, X Hao, J Ying, Y Tan, L He, W Wang, N Chen |
Acta Pharmacologica Sinica | 2016 |
Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft: PGNMID and IgAN in renal allograft
A Sawada, K Kawanishi, S Horita, J Koike, K Honda, A Ochi, M Komoda, Y Tanaka, K Unagami, M Okumi, T Shimizu, H Ishida, K Tanabe, Y Nagashima, K Nitta |
Nephrology | 2016 |
Validation study of Oxford Classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining: IgAN Oxford Classification validation
G Ştefan, G Ismail, S Stancu, A Zugravu, A Andronesi, E Mandache, G Mircescu |
Pathology International | 2016 |
The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn’s disease
T Terasaka, HA Uchida, R Umebayashi, K Tsukamoto, K Tanaka, M Kitagawa, H Sugiyama, H Tanioka, J Wada |
BMC Nephrology | 2016 |
Advances in Experimental Medicine and Biology
M Mizerska-Wasiak, A Turczyn, A Such, K Cichoń-Kawa, J Małdyk, M Miklaszewska, J Pietrzyk, A Rybi-Szumińska, A Wasilewska, A Firszt-Adamczyk, R Stankiewicz, M Szczepańska, B Bieniaś, M Zajączkowska, A Pukajło-Marczyk, D Zwolińska, K Siniewicz-Luzeńczyk, M Tkaczyk, K Gadomska-Prokop, R Grenda, U Demkow, M Pańczyk-Tomaszewska |
Advances in experimental medicine and biology | 2016 |
Systemic Vasculitides: Current Status and Perspectives
E Tombetti, E Baldissera, AA Manfredi, MG Sabbadini |
Systemic Vasculitides: Current Status and Perspectives | 2016 |
Presence of Streptococcus mutans strains harbouring the cnm gene correlates with dental caries status and IgA nephropathy conditions
T Misaki, S Naka, R Hatakeyama, A Fukunaga, R Nomura, T Isozaki, K Nakano |
Scientific Reports | 2016 |
IgA nephropathy enigma
J Mestecky, J Novak, Z Moldoveanu, M Raska |
Clinical Immunology | 2016 |
Pathogenesis and Treatment in IgA Nephropathy
Y Tomino |
2016 | |
Aberrantly methylated DNA regions lead to low activation of CD4+ T-cells in IgA nephropathy
F Sallustio, G Serino, SN Cox, AD Gassa, C Curci, GD Palma, B Banelli, G Zaza, M Romani, FP Schena |
Clinical Science | 2016 |
Update on immunoglobulin A nephropathy, Part I: Pathophysiology
M Salvadori |
World Journal of Nephrology | 2015 |
Molecular Insights into the Pathogenesis of IgA Nephropathy
T Robert, L Berthelot, A Cambier, E Rondeau, RC Monteiro |
Trends in Molecular Medicine | 2015 |
Role of IgA receptors in the pathogenesis of IgA nephropathy
SM Lechner, C Papista, JM Chemouny, L Berthelot, RC Monteiro |
Journal of Nephrology | 2015 |
New Insights into the Pathogenesis of IgA Nephropathy
J Novak, D Rizk, K Takahashi, XW Zhang, Q Bian, H Ueda, Y Ueda, C Reily, LY Lai, C Hao, L Novak, ZQ Huang, MB Renfrow, H Suzuki, BA Julian |
Kidney Diseases | 2015 |
Paradigm shift in activity assessment of IgA nephropathy – optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting
Y Suzuki, H Suzuki, J Yasutake, Y Tomino |
Expert Opinion on Biological Therapy | 2015 |
The long-term efficacy and safety of immunosuppressive therapy on the progression of IgA nephropathy: a meta-analysis of controlled clinical trials with more than 5-year follow-up
L Tian, X Shao, Y Xie, L Wang, Q Wang, X Che, Z Ni, S Mou |
Expert Opinion on Pharmacotherapy | 2015 |
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)
R Plomp, G Dekkers, Y Rombouts, R Visser, CA Koeleman, GS Kammeijer, BC Jansen, T Rispens, PJ Hensbergen, G Vidarsson, M Wuhrer |
Molecular & cellular proteomics : MCP | 2015 |
Long-Term Therapeutic Plasma Exchange to Prevent End-Stage Kidney Disease in Adult Severe Resistant Henoch-Schonlein Purpura Nephritis
P Hamilton, O Ogundare, A Raza, A Ponnusamy, J Gorton, H Alachkar, J Choudhury, J Barratt, PA Kalra |
Case Reports in Nephrology | 2015 |
Pediatric Nephrology
ED Avner, WE Harmon, P Niaudet, N Yoshikawa, F Emma, S Goldstein |
Pediatric Nephrology | 2015 |
SpringerReference Innere Medizin: herausgegeben von Hendrik Lehnert
H Lehnert, SM Schellong, J Mössner, CC Sieber, W Swoboda, A Neubauer, B Kemkes-Matthes, MP Manns, J Rupp, G Hasenfuß, J Floege, M Hallek, T Welte, M Lerch, E Märker-Hermann, LS Weilemann |
2015 | |
The genetics and immunobiology of IgA nephropathy
Krzysztof Kiryluk, Jan Novak |
Journal of Clinical Investigation | 2014 |
Cytokines Alter IgA1 O-Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes*
H Suzuki, M Raska, K Yamada, Z Moldoveanu, BA Julian, RJ Wyatt, Y Tomino, AG Gharavi, J Novak |
The Journal of biological chemistry | 2014 |
IgA Nephropathy Caused by Unusual Polymerization of IgA1 with Aberrant N-Glycosylation in a Patient with Monoclonal Immunoglobulin Deposition Disease
Y Narimatsu, A Kuno, H Ito, H Kaji, S Kaneko, J Usui, K Yamagata, H Narimatsu, IC Moura |
PloS one | 2014 |
Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
C Reily, H Ueda, ZQ Huang, J Mestecky, BA Julian, CD Willey, J Novak |
Journal of Immunology Research | 2014 |
New insights into the pathogenesis of IgA nephropathy
J Floege, IC Moura, MR Daha |
Seminars in Immunopathology | 2014 |
Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy
Y Suzuki, K Matsuzaki, H Suzuki, K Okazaki, H Yanagawa, N Ieiri, M Sato, T Sato, Y Taguma, J Matsuoka, S Horikoshi, J Novak, O Hotta, Y Tomino |
Clinical and Experimental Nephrology | 2014 |
Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy
J Nakata, Y Suzuki, H Suzuki, D Sato, T Kano, H Yanagawa, K Matsuzaki, S Horikoshi, J Novak, Y Tomino |
PloS one | 2014 |
A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases
H Yanagawa, H Suzuki, Y Suzuki, K Kiryluk, AG Gharavi, K Matsuoka, Y Makita, BA Julian, J Novak, Y Tomino |
PloS one | 2014 |
Enzymatic sialylation of IgA1 o-glycans: implications for studies of IgA nephropathy
K Takahashi, M Raska, MS Horynova, SD Hall, K Poulsen, M Kilian, Y Hiki, Y Yuzawa, Z Moldoveanu, BA Julian, MB Renfrow, J Novak |
PloS one | 2014 |
Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy
K Satake, Y Shimizu, Y Sasaki, H Yanagawa, H Suzuki, Y Suzuki, S Horikoshi, S Honda, K Shibuya, A Shibuya, Y Tomino |
BMC Nephrology | 2014 |
Development of animal models of human IgA nephropathy
H Suzuki, Y Suzuki, J Novak, Y Tomino |
Drug Discovery Today: Disease Models | 2014 |
Immune profile of IgA-dominant diffuse proliferative glomerulonephritis
E Wallace, N Maillard, H Ueda, S Hall, H Fatima, J Novak, BA Julian |
Clinical Kidney Journal | 2014 |
Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers
Y Suzuki, H Suzuki, Y Makita, A Takahata, K Takahashi, M Muto, Y Sasaki, A Kelimu, K Matsuzaki, H Yanagawa, K Okazaki, Y Tomino |
International journal of nephrology and renovascular disease | 2014 |
N-Acetylgalactosaminide 2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy
MS Horynova, A Vrablikova, TJ Stewart, K Takahashi, L Czernekova, K Yamada, H Suzuki, BA Julian, MB Renfrow, J Novak, M Raska |
Nephrology Dialysis Transplantation | 2014 |
The Combined Role of Galactose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for IgA Nephropathy
R Schmitt, A Stahl, AI Olin, AC Kristoffersson, J Rebetz, J Novak, G Lindahl, D Karpman |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathy
M Aizawa, Y Suzuki, H Suzuki, H Pang, M Kihara, J Nakata, K Yamaji, S Horikoshi, Y Tomino |
PloS one | 2014 |
O-Linked Glycosylation Determines the Nephritogenic Potential of IgA Rheumatoid Factor
M Kihara, K Ito, J Nakata, M Otani, NL Tran, N Morito, S Takahashi, Y Wada, S Izui |
Journal of the American Society of Nephrology : JASN | 2014 |
Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region
Y Hiki, H Hori, K Yamamoto, Y Yamamoto, Y Yuzawa, N Kitaguchi, K Takahashi |
Journal of Nephrology | 2014 |
Biomarkers in IgA nephropathy
VJ Hwang, A Ulu, J Hoorebeke, RH Weiss |
Biomarkers in Medicine | 2014 |
The etiology of glomerulonephritis: roles of infection and autoimmunity
WG Couser, RJ Johnson |
Kidney International | 2014 |
Impact of autoantibody glycosylation in autoimmune diseases
R Goulabchand, T Vincent, F Batteux, J Eliaou, P Guilpain |
Autoimmunity Reviews | 2014 |
A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases
H Yanagawa, H Suzuki, Y Suzuki, K Kiryluk, AG Gharavi, K Matsuoka, Y Makita, BA Julian, J Novak, Y Tomino, SK Ahuja |
PloS one | 2014 |
Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
J Nakata, Y Suzuki, H Suzuki, D Sato, T Kano, H Yanagawa, K Matsuzaki, S Horikoshi, J Novak, Y Tomino, IC Moura |
PloS one | 2014 |
Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
K Takahashi, M Raska, MS Horynova, SD Hall, K Poulsen, M Kilian, Y Hiki, Y Yuzawa, Z Moldoveanu, BA Julian, MB Renfrow, J Novak, IC Moura |
PloS one | 2014 |
Pathogenesis of Immunoglobulin A Nephropathy: Recent Insight from Genetic Studies
K Kiryluk, J Novak, AG Gharavi |
Annual Review of Medicine | 2013 |
Biomarkers in IgA nephropathy: relationship to pathogenetic hits
MC Hastings, Z Moldoveanu, H Suzuki, F Berthoux, BA Julian, JT Sanders, MB Renfrow, J Novak, RJ Wyatt |
Expert Opinion on Medical Diagnostics | 2013 |
Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: Role of cysteine alkylation during sample processing
V Franc, P Řehulka, M Raus, J Stulík, J Novak, MB Renfrow, M Šebela |
Journal of Proteomics | 2013 |
FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy
X Zhou, F Cheng, Y Qi, Y Zhao, P Hou, L Zhu, J Lv, H Zhang |
PloS one | 2013 |
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich |
Seldin and Giebisch's The Kidney | 2013 |
IgA Nephropathy: Molecular Mechanisms of the Disease
J Mestecky, M Raska, BA Julian, AG Gharavi, MB Renfrow, Z Moldoveanu, L Novak, K Matousovic, J Novak |
Annual review of pathology | 2013 |
Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy
R Kolka, H Valdimarsson, M Bodvarsson, S Hardarson, T Jonsson |
APMIS | 2013 |
Currently available and potential future treatment options for IgA nephropathy
MJ Kim, FW Tam |
Expert Opinion on Orphan Drugs | 2013 |
Pathogenesis of immunoglobulin A nephropathy:
J Novak, MB Renfrow, AG Gharavi, BA Julian |
Current Opinion in Nephrology and Hypertension | 2013 |
Antibody Glycosylation and Inflammation
KT Shade, R Anthony |
Antibodies | 2013 |
Glomerular Diseases: Emerging Tests and Therapies for IgA Nephropathy
PA Canetta, K Kiryluk, GB Appel |
Clinical journal of the American Society of Nephrology : CJASN | 2013 |
Formation des dépôts d’IgA dans la maladie de Berger : ce que révèle le modèle animal
L Berthelot, RC Monteiro |
Biologie Aujourd hui | 2013 |
N-acetylgalactosamine exposure of serum IgA1 was associated with glomerulosclerosis and tubular atrophy/interstitial fibrosis of IgA nephropathy patients: N-acetylgalactosamine and IgA nephropathy
LX Xu, Z Ye, Z Feng, G Xin, B Zhang, S Liu, R Li, Z Li, X Liang, W Shi |
Nephrology | 2013 |
Glycosylation des autoanticorps au cours des maladies auto-immunes
R Goulabchand, F Batteux, P Guilpain |
La Revue de Médecine Interne | 2013 |
FCGR2B and FCRLB Gene Polymorphisms Associated with IgA Nephropathy
X Zhou, F Cheng, Y Qi, Y Zhao, P Hou, L Zhu, J Lv, H Zhang, IC Moura |
PloS one | 2013 |
Core Concepts in Parenchymal Kidney Disease
FC Fervenza, J Lin, S Sethi, AK Singh |
2013 | |
Spleen tyrosine kinase is important in the production of proinflammatory cytokines and cell proliferation in human mesangial cells following stimulation with IgA1 isolated from IgA nephropathy patients
MJ Kim, JP McDaid, SP McAdoo, J Barratt, K Molyneux, ES Masuda, CD Pusey, FW Tam |
Journal of immunology (Baltimore, Md. : 1950) | 2012 |
Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy
G Serino, F Sallustio, SN Cox, F Pesce, FP Schena |
Journal of the American Society of Nephrology : JASN | 2012 |
The Glomerular Filtration Barrier: Components and Crosstalk
MC Menon, PY Chuang, CJ He |
International Journal of Nephrology | 2012 |
Pathogenesis of IgA nephropathy
KN Lai |
Nature Reviews Nephrology | 2012 |
Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease
T Inoue, H Iijima, M Tajiri, S Shinzaki, E Shiraishi, S Hiyama, A Mukai, S Nakajima, H Iwatani, T Nishida, T Mizushima, T Yasui, Y Isaka, T Kanto, M Tsujii, E Miyoshi, Y Wada, T Takehara |
Inflammatory Bowel Diseases | 2012 |
Suppression of Adiponectin by Aberrantly Glycosylated IgA1 in Glomerular Mesangial Cells In Vitro and In Vivo
T Inoue, H Sugiyama, M Kitagawa, K Takiue, H Morinaga, A Ogawa, Y Kikumoto, S Kitamura, Y Maeshima, H Makino |
PloS one | 2012 |
Glycosylation of IgA1 and pathogenesis of IgA nephropathy
J Novak, BA Julian, J Mestecky, MB Renfrow |
Seminars in Immunopathology | 2012 |
Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma
MS Horynová, M Raška, H Clausen, J Novak |
Cellular and Molecular Life Sciences | 2012 |
In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells
T Yanagihara, R Brown, S Hall, Z Moldoveanu, A Goepfert, M Tomana, BA Julian, J Mestecky, J Novak |
Results in Immunology | 2012 |
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy
F Berthoux, H Suzuki, L Thibaudin, H Yanagawa, N Maillard, C Mariat, Y Tomino, BA Julian, J Novak |
Journal of the American Society of Nephrology : JASN | 2012 |
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
L Berthelot, C Papista, TT Maciel, M Biarnes-Pelicot, E Tissandie, PH Wang, H Tamouza, A Jamin, J Bex-Coudrat, A Gestin, A Boumediene, M Arcos-Fajardo, P England, E Pillebout, F Walker, E Daugas, F Vrtosvnik, M Flamant, M Benhamou, M Cogne, IC Moura, RC Monteiro |
Journal of Experimental Medicine | 2012 |
Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy
Y Wada, H Ogata, Y Takeshige, A Takeshima, N Yoshida, M Yamamoto, H Ito, E Kinugasa |
Clinical and Experimental Nephrology | 2012 |
Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy
TM Eison, MC Hastings, Z Moldoveanu, JT Sanders, L Gaber, PD Walker, KK Lau, BA Julian, J Novak, RJ Wyatt |
Clinical nephrology | 2012 |
The IgA1 immune complex–mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy
H Tamouza, JM Chemouny, LR Kafkova, L Berthelot, M Flamant, M Demion, L Mesnard, E Paubelle, F Walker, BA Julian, E Tissandié, MK Tiwari, NO Camara, F Vrtovsnik, M Benhamou, J Novak, RC Monteiro, IC Moura |
Kidney International | 2012 |
C1GALT1 polymorphisms are associated with Henoch–Schönlein purpura nephritis
X He, P Zhao, S Kang, Y Ding, J Luan, Z Liu, Y Wu, W Yin |
Pediatric Nephrology | 2012 |
Immunoglobulin A Nephropathy Associated with Plasmodium falciparum Malaria
DE Yoo, JH Kim, JH Kie, Y Park, TI Chang, HJ Oh, SJ Kim, TH Yoo, KH Choi, SW Kang, SH Han |
Journal of Korean Medical Science | 2012 |
IgA nephropathy and oxidative stress: news on clinically evaluated biomarkers hits the stage
C Zhu, PR Mertens |
International Urology and Nephrology | 2012 |
Integrin 1/ 1 and 2/ 1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy
Y Kaneko, T Otsuka, Y Tsuchida, F Gejyo, I Narita |
International Immunology | 2012 |
Brenner and Rector's The Kidney
C Brugnara, KU Eckardt |
Brenner and Rector's The Kidney | 2012 |
The IgA1 immune complex–mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy
H Tamouza, JM Chemouny, LR Kafkova, L Berthelot, M Flamant, M Demion, L Mesnard, E Paubelle, F Walker, BA Julian, E Tissandié, MK Tiwari, NO Camara, F Vrtovsnik, M Benhamou, J Novak, RC Monteiro, IC Moura |
Kidney International | 2012 |
Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia
M Shimizu, H Kanegane, T Wada, Y Motoyoshi, T Morio, F Candotti, A Yachie |
Journal of Allergy and Clinical Immunology | 2012 |
Jacalin regulates IgA production by peripheral blood mononuclear cells
K Miyamoto, T Chiba, N Shinohara, Y Nagata, N Asakawa, S Kato, N Mizutani, T Murata, S Nomura, T Horiuchi |
Immunotherapy | 2012 |
MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders
Y Yuan, S Kasar, C Underbayev, S Prakash, E Raveche |
Leukemia Research and Treatment | 2012 |
Suppression of Adiponectin by Aberrantly Glycosylated IgA1 in Glomerular Mesangial Cells In Vitro and In Vivo
T Inoue, H Sugiyama, M Kitagawa, K Takiue, H Morinaga, A Ogawa, Y Kikumoto, S Kitamura, Y Maeshima, H Makino, NO Câmara |
PloS one | 2012 |
Mice Over-expressing BAFF Develop a Commensal Flora-Dependent, IgA-Associated Nephropathy
Douglas McCarthy, Julie Kujawa, Cheryl Wilson, Adrian Papandile, Urjana Poreci, Elisa Porfilio, Lesley Ward, Melissa Lawson, Andrew MacPherson, Kathleen McCoy, York Pei, Lea Novak, Jeannette Lee, Bruce Jilian, Jan Novak, Ann Ranger, Jennifer Gommerman, Jeffrey Browning |
Journal of Clinical Investigation | 2011 |
Dysfunctions of the Iga system: a common link between intestinal and renal diseases
C Papista, L Berthelot, RC Monteiro |
Cellular and Molecular Immunology | 2011 |
Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
M Tanaka, G Seki, T Someya, M Nagata, T Fujita |
Clinical and Developmental Immunology | 2011 |
IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells
J Novak, LR Kafkova, H Suzuki, M Tomana, K Matousovic, R Brown, S Hall, JT Sanders, TM Eison, Z Moldoveanu, L Novak, Z Novak, R Mayne, BA Julian, J Mestecky, RJ Wyatt |
Nephrology Dialysis Transplantation | 2011 |
Production of N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) fused with secretory signal Igκ in insect cells
M Horynová, K Takahashi, S Hall, MB Renfrow, J Novak, M Raška |
Protein Expression and Purification | 2011 |
Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency
M Shimizu, NP Nikolov, K Ueno, K Ohta, RM Siegel, A Yachie, F Candotti |
Clinical Immunology | 2011 |
Naturally occurring structural isomers in serum IgA1 o-glycosylation
K Takahashi, AD Smith, K Poulsen, M Kilian, BA Julian, J Mestecky, J Novak, MB Renfrow |
Journal of Proteome Research | 2011 |
The pathophysiology of IgA nephropathy
H Suzuki, K Kiryluk, J Novak, Z Moldoveanu, AB Herr, MB Renfrow, RJ Wyatt, F Scolari, J Mestecky, AG Gharavi, BA Julian |
Journal of the American Society of Nephrology : JASN | 2011 |
Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis
K Kiryluk, Z Moldoveanu, JT Sanders, TM Eison, H Suzuki, BA Julian, J Novak, AG Gharavi, RJ Wyatt |
Kidney international. Supplement | 2011 |
O -Glycosylated IgA Rheumatoid Factor Induces IgA Deposits and Glomerulonephritis
M Otani, J Nakata, M Kihara, V Leroy, S Moll, Y Wada, S Izui |
Journal of the American Society of Nephrology : JASN | 2011 |
The pathogenesis of IgA nephropathy
RJ Glassock |
Current Opinion in Nephrology and Hypertension | 2011 |
Genome-wide association study identifies susceptibility loci for IgA nephropathy
AG Gharavi, K Kiryluk, M Choi, Y Li, P Hou, J Xie, S Sanna-Cherchi, CJ Men, BA Julian, RJ Wyatt, J Novak, JC He, H Wang, J Lv, L Zhu, W Wang, Z Wang, K Yasuno, M Gunel, S Mane, S Umlauf, I Tikhonova, I Beerman, S Savoldi, R Magistroni, GM Ghiggeri, M Bodria, F Lugani, P Ravani, C Ponticelli, L Allegri, G Boscutti, G Frasca, A Amore, L Peruzzi, R Coppo, C Izzi, BF Viola, E Prati, M Salvadori, R Mignani, L Gesualdo, F Bertinetto, P Mesiano, A Amoroso, F Scolari, N Chen, H Zhang, RP Lifton |
Nature Genetics | 2011 |
Gammopathy with IgA mesangial deposition provides a monoclonal model of IgA nephritogenicity and new insights into its molecular mechanisms
A Boumediene, C Oblet, Z Oruc, S Duchez, W Morelle, A Huynh, J Pourrat, JC Aldigier, M Cogne |
Nephrology Dialysis Transplantation | 2011 |
Primary IgA Nephropathy: New Insights Into Pathogenesis
J Barratt, J Feehally |
Seminars in Nephrology | 2011 |
Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89–IgA and IgG–IgA complexes: common mechanisms for distinct diseases
E Tissandié, W Morelle, L Berthelot, F Vrtovsnik, E Daugas, F Walker, D Lebrec, JM Trawalé, C Francoz, F Durand, IC Moura, V Paradis, R Moreau, RC Monteiro |
Kidney International | 2011 |
The Pathogenesis of IgA Nephropathy: What is New and How Does it Change Therapeutic Approaches?
J Floege |
American Journal of Kidney Diseases | 2011 |
Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition
M Raska, K Takahashi, L Czernekova, K Zachova, S Hall, Z Moldoveanu, MC Elliott, L Wilson, R Brown, D Jancova, S Barnes, J Vrbkova, M Tomana, PD Smith, J Mestecky, MB Renfrow, J Novak |
The Journal of biological chemistry | 2010 |
Galactosylation of Serum IgA1 O-Glycans in Celiac Disease
K Lindfors, H Suzuki, J Novak, P Collin, P Saavalainen, LL Koskinen, M Mäki, K Kaukinen |
Journal of Clinical Immunology | 2010 |
Down-regulation of core 1 beta1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1
K Yamada, N Kobayashi, T Ikeda, Y Suzuki, T Tsuge, S Horikoshi, SN Emancipator, Y Tomino |
Nephrology Dialysis Transplantation | 2010 |
Genetic studies of IgA nephropathy: past, present, and future
K Kiryluk, BA Julian, RJ Wyatt, F Scolari, H Zhang, J Novak, AG Gharavi |
Pediatric nephrology (Berlin, Germany) | 2010 |
Clustered O-Glycans of IgA1
K Takahashi, SB Wall, H Suzuki, AD 4th, S Hall, K Poulsen, M Kilian, JA Mobley, BA Julian, J Mestecky, J Novak, MB Renfrow |
Molecular & cellular proteomics : MCP | 2010 |
Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study
MM Gomes, H Suzuki, MT Brooks, M Tomana, Z Moldoveanu, J Mestecky, BA Julian, J Novak, AB Herr |
Biochemistry | 2010 |
Galactose-Deficient IgA1 in African Americans with IgA Nephropathy: Serum Levels and Heritability
MC Hastings, Z Moldoveanu, BA Julian, J Novak, JT Sanders, KR McGlothan, AG Gharavi, RJ Wyatt |
Clinical journal of the American Society of Nephrology : CJASN | 2010 |
Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1
SL Hu, GA Colvin, A Rifai, H Suzuki, J Novak, A Esparza, S Farooqi, BA Julian |
Nephrology Dialysis Transplantation | 2010 |
Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines
EM Yoo, LJ Yu, LA Wims, D Goldberg, SL Morrison |
mAbs | 2010 |
Establishment of a Mouse IgA Nephropathy Model With the MBP-20-Peptide Fusion Protein
L Zhang, F Ye, Y He, D Kong, C Han, Z Zhao, J Zhu, H Meng, X Liu, X Jin |
The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology | 2010 |
Effect of Glycosylation onCis/TransIsomerization of Prolines in IgA1-Hinge Peptide
Y Narimatsu, T Kubota, S Furukawa, H Morii, H Narimatsu, K Yamasaki |
Journal of the American Chemical Society | 2010 |
Commentaries on ‘Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura’
M Zaffanello, F Emma, PF Weiss, MC Hastings, TM Eison, RJ Wyatt |
Evidence-Based Child Health: A Cochrane Review Journal | 2010 |
Glomérulonéphrite à dépôts mésangiaux d’IgA
É Pillebout, D Nochy |
Néphrologie & Thérapeutique | 2010 |
Clustered O -Glycans of IgA1: DEFINING MACRO- AND MICROHETEROGENEITY BY USE OF ELECTRON CAPTURE/TRANSFER DISSOCIATION
K Takahashi, SB Wall, H Suzuki, AD Smith, S Hall, K Poulsen, M Kilian, JA Mobley, BA Julian, J Mestecky, J Novak, MB Renfrow |
Molecular & cellular proteomics : MCP | 2010 |
Recognition of Galactose-Deficient O -Glycans in the Hinge Region of IgA1 by N -Acetylgalactosamine-Specific Snail Lectins: A Comparative Binding Study
MM Gomes, H Suzuki, MT Brooks, M Tomana, Z Moldoveanu, J Mestecky, BA Julian, J Novak, AB Herr |
Biochemistry | 2010 |
Aberrantly Glycosylated IgA1 in IgA Nephropathy Patients is Recognized by IgG Antibodies with Restricted Heterogeneity
Hitoshi Suzuki, Run Fan, Zhixin Zhang, Rhubell Brown, Stacy Hall, Bruce A. Julian, W. Winn Chatham, Yusuke Suzuki, Robert J. Wyatt, Zina Moldoveanu, Jeannette Y. Lee, James Robinson, Milan Tomana, Yasuhiko Tomino, Jiri Mestecky, Jan Novak |
Journal of Clinical Investigation | 2009 |
Role of IgA and IgA Fc Receptors in Inflammation
RC Monteiro |
Journal of Clinical Immunology | 2009 |
Pathogenesis of Henoch-Schönlein purpura nephritis
KK Lau, H Suzuki, J Novak, RJ Wyatt |
Pediatric Nephrology | 2009 |
Vasculitis of small blood vessels - some riddles about IgA and about the complexity of transmigration
C Sunderkötter |
Experimental Dermatology | 2009 |
Pathogenetic Analyses of IgA nephropathy from the aspect of O-glycans in IgA1 hinge region
Y Hiki |
Nihon Shoni Jinzobyo Gakkai Zasshi | 2009 |
IgA nephropathy--the case for a genetic basis becomes stronger
K Kiryluk, AG Gharavi, C Izzi, F Scolari |
Nephrology Dialysis Transplantation | 2009 |
Tissue distribution and biological activities of immune complexes are determined by their size and composition
K Matousovic, J Novak, BA Julian, J Mestecky |
Nephrology Dialysis Transplantation | 2009 |
IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy
A Jacquet, H Francois, C Frangie, Y Yahiaoui, S Ferlicot, C Micelli, X Mariette, A Durrbach |
Nephrology Dialysis Transplantation | 2009 |
Genetic Diseases of the Kidney
K Ichida, M Hosoyamada, T Hosoya, H Endou |
Genetic Diseases of the Kidney | 2009 |
Challenges to enigmas in the pathogenesis of IgA nephropathy
Y Suzuki |
Juntendo Medical Journal | 2009 |
O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy
Y Hiki |
Clinical and Experimental Nephrology | 2009 |
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly-glycosylated IgA1
Hitoshi Suzuki, Zina Moldoveanu, Stacy Hall, Rhubell Brown, Huong L. Vu, Lea Novak, Bruce A. Julian, Milan Tomana, Robert J. Wyatt, Jeffrey C. Edberg, Graciella S. Alarcón, Robert P. Kimberly, Yasuhiko Tomino, Jiri Mestecky, Jan Novak |
Journal of Clinical Investigation | 2008 |
Potential Immunopathogenic Role of the Mucosa–Bone Marrow Axis in IgA Nephropathy: Insights From Animal Models
Y Suzuki, Y Tomino |
Seminars in Nephrology | 2008 |
Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy
I Narita, F Gejyo |
Clinical and Experimental Nephrology | 2008 |
Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding
MM Gomes, SB Wall, K Takahashi, J Novak, MB Renfrow, AB Herr |
Biochemistry | 2008 |
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy
J Novak, BA Julian, M Tomana, J Mestecky |
Seminars in Nephrology | 2008 |
Role of Aberrant Glycosylation of IgA1 Molecules in the Pathogenesis of IgA Nephropathy
J Mestecky, M Tomana, Z Moldoveanu, BA Julian, H Suzuki, K Matousovic, MB Renfrow, L Novak, RJ Wyatt, J Novak |
Kidney and Blood Pressure Research | 2008 |
Recent insights into the biological roles of mucin-type O-glycosylation
E Tian, KG Hagen |
Glycoconjugate Journal | 2008 |
T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy
SR Chintalacharuvu, M Yamashita, N Bagheri, TG Blanchard, JG Nedrud, ME Lamm, Y Tomino, SN Emancipator |
Clinical & Experimental Immunology | 2008 |
Sweet preferences of MGL: carbohydrate specificity and function
SJ van Vliet, E Saeland, Y Kooyk |
Trends in Immunology | 2008 |
Gastrointestinal Manifestations of Henoch-Schonlein Purpura
EC Ebert |
Digestive Diseases and Sciences | 2008 |
Capillary electrophoresis–mass spectrometry in urinary proteome analysis: current applications and future developments
J Metzger, JP Schanstra, H Mischak |
Analytical and Bioanalytical Chemistry | 2008 |
The Glomerular Response to IgA Deposition in IgA Nephropathy
IC Moura, M Benhamou, P Launay, F Vrtovsnik, U Blank, RC Monteiro |
Seminars in Nephrology | 2008 |
Secondary IgA Nephropathy
S Pouria, J Barratt |
Seminars in Nephrology | 2008 |
Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
AG Gharavi, Z Moldoveanu, RJ Wyatt, CV Barker, SY Woodford, RP Lifton, J Mestecky, J Novak, BA Julian |
Journal of the American Society of Nephrology : JASN | 2008 |
Analysis of IgA1 N -Glycosylation and Its Contribution to FcαRI Binding
MM Gomes, SB Wall, K Takahashi, J Novak, MB Renfrow, AB Herr |
Biochemistry | 2008 |
Protective role of anti-synthetic hinge peptide antibody for glomerular deposition of hypoglycosylated IgA1
Y Hiki, K Takahashi, S Shimozato, H Odani, K Yamamoto, M Tomita, M Hasegawa, K Murakami, K Nabeshima, S Nakai, Y Fujita, I Ishida, H Iwase, S Sugiyama |
Clinical and Experimental Nephrology | 2008 |
Development of Immunoglobulin A Nephropathy- Like Disease in β-1,4-Galactosyltransferase-I-Deficient Mice
T Nishie, O Miyaishi, H Azuma, A Kameyama, C Naruse, N Hashimoto, H Yokoyama, H Narimatsu, T Wada, M Asano |
The American Journal of Pathology | 2007 |
Body Fluid Proteomics for Biomarker Discovery: Lessons from the Past Hold the Key to Success in the Future
DM Good, V Thongboonkerd, J Novak, JL Bascands, JP Schanstra, JJ Coon, A Dominiczak, H Mischak |
Journal of Proteome Research | 2007 |
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Z Moldoveanu, RJ Wyatt, JY Lee, M Tomana, BA Julian, J Mestecky, WQ Huang, SR Anreddy, S Hall, MC Hastings, KK Lau, WJ Cook, J Novak |
Kidney International | 2007 |
Hypercomplementemia in adult patients with IgA nephropathy
K Onda, H Ohi, M Tamano, I Ohsawa, M Wakabayashi, S Horikoshi, T Fujita, Y Tomino |
Journal of Clinical Laboratory Analysis | 2007 |
Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells
H Suzuki, Y Suzuki, M Aizawa, T Yamanaka, M Kihara, H Pang, S Horikoshi, Y Tomino |
Kidney International | 2007 |
The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy (Review Article)
J Barratt, AC Smith, J Feehally |
Nephrology | 2007 |
The genetics of IgA nephropathy
I Beerman, J Novak, RJ Wyatt, BA Julian, AG Gharavi |
Nature Clinical Practice Nephrology | 2007 |
Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells
M Raska, Z Moldoveanu, H Suzuki, R Brown, R Kulhavy, J Andrasi, S Hall, HL Vu, F Carlsson, G Lindahl, M Tomana, BA Julian, RJ Wyatt, J Mestecky, J Novak |
Journal of Molecular Biology | 2007 |
Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules
YH Gao, LX Xu, JJ Zhang, Y Zhang, MH Zhao, HY Wang |
Clinical & Experimental Immunology | 2007 |
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins
JS Moore, R Kulhavy, M Tomana, Z Moldoveanu, H Suzuki, R Brown, S Hall, M Kilian, K Poulsen, J Mestecky, BA Julian, J Novak |
Molecular Immunology | 2007 |
Immunopathogenesis of IgAN
J Barratt, AC Smith, K Molyneux, J Feehally |
Seminars in Immunopathology | 2007 |
The genetic susceptibility to IgA nephropathy: A novel functional candidate gene for incomplete O-glycosylation of IgA1
I Narita, Y Kaneko, D Kondo, S Goto, M Sakatsume, F Gejyo |
Kidney International | 2007 |
Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases
BA Julian, S Wittke, M Haubitz, P Zürbig, E Schiffer, BM McGuire, RJ Wyatt, J Novak |
World Journal of Urology | 2007 |
Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura
KK Lau, RJ Wyatt, Z Moldoveanu, M Tomana, BA Julian, RJ Hogg, JY Lee, WQ Huang, J Mestecky, J Novak |
Pediatric Nephrology | 2007 |
Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy
MB Renfrow, CL Mackay, MJ Chalmers, BA Julian, J Mestecky, M Kilian, K Poulsen, MR Emmett, AG Marshall, J Novak |
Analytical and Bioanalytical Chemistry | 2007 |
Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy
JX Ding, LX Xu, JC Lv, MH Zhao, H Zhang, HY Wang |
Clinical Immunology | 2007 |
Glycosylation Profile of Differently Charged IgA1 and Their Binding Characteristics to Cultured Mesangial Cells in IgA Nephropathy
JC Leung, LY Chan, SC Tang, PC Tam, J Fenn, KN Lai |
Nephron Experimental Nephrology | 2007 |
Mucosal Immune Defense: Immunoglobulin A
CS Kaetzel |
2007 | |
Th2 cytokine induces aberrant O-glycosylation in the hinge region of IgA1 via downregulation of core1β1, 3-galactosyltransferase and its molecular chaperone Cosmc
K Yamada, N Kobayashi, T Ikeda, Y Suzuki, T Tsuge, S Horikoshi, Y Tomino |
Juntendo Medical Journal | 2007 |
Concurrent Antiglomerular Basement Membrane Disease and Immune Complex Glomerulonephritis
Z Cui, MH Zhao, SX Wang, G Liu, WZ Zou, HY Wang |
Renal Failure | 2006 |
Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy
Y Yan, LX Xu, JJ Zhang, Y Zhang, MH Zhao |
Clinical & Experimental Immunology | 2006 |
A destructive nasal lesion and glomerulonephritis
FP Wilson, SH Nasr, GS Markowitz, EC Naylor, PL Sterman, VD D'Agati |
Kidney International | 2006 |
IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential
MM Gomes, AB Herr |
Springer Seminars in Immunopathology | 2006 |
Reconciling solvent effects on rotamer populations in carbohydrates A joint MD and NMR analysis
J Gonzalez-Outeiriño, KN Kirschner, S Thobhani, RJ Woods |
Canadian Journal of Chemistry | 2006 |
IgA nephropathy in two adolescent sisters heterozygous for Fabry disease
C Whybra, A Schwarting, J Kriegsmann, A Gal, E Mengel, C Kampmann, F Baehner, E Schaefer, M Beck |
Pediatric Nephrology | 2006 |
Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells
J Zhang, L Xu, Y Zhang, M Zhao |
Clinical Immunology | 2006 |
Experimental model of IgA nephropathy using KM mouse (second report): Possible protective effect of anti-IgA1 synthetic hinge peptide antibody on glomerular deposition of underglycosylated IgA1
Y Hiki, K Takahashi, M Itoh, K Inoue, M Tomita, M Hasegawa, K Murakami, K Nabeshima, I Ishida, H Iwase, S Sugiyama |
Nephrology | 2006 |
Increased Prevalence of Anti-Gliadin IgA-Antibodies with Aberrant Duodenal Histopathological Findings in Patients with IgA-Nephropathy and Related Disorders
G Almroth, T Axelsson, E Müssener, E Grodzinsky, G Midhagen, P Olcén |
Upsala Journal of Medical Sciences | 2006 |
Glomérulonéphrite à dépôts mésangiaux d'IgA
E Pillebout, D Nochy |
EMC - Néphrologie | 2006 |
IgA-containing immune complexes in the urine of IgA nephropathy patients
K Matousovic, J Novak, T Yanagihara, M Tomana, Z Moldoveanu, R Kulhavy, BA Julian, K Konecny, J Mestecky |
Nephrology Dialysis Transplantation | 2006 |
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells
J Novak, M Tomana, K Matousovic, R Brown, S Hall, L Novak, BA Julian, RJ Wyatt, J Mestecky |
Kidney International | 2005 |
Role of macromolecular IgA in IgA nephropathy
PJ van der Boog, C Kooten, JW de Fijter, MR Daha |
Kidney International | 2005 |
The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy
LX Xu, Y Yan, JJ Zhang, Y Zhang, MH Zhao |
Clinical & Experimental Immunology | 2005 |
The function of immunoglobulin A in immunity
JM Woof, MA Kerr |
The Journal of Pathology | 2005 |
IgA: An immune glycoprotein
EM Yoo, SL Morrison |
Clinical Immunology | 2005 |
Small bowel cyclooxygenase 2 (COX-2) expression in patients with IgA nephropathy
T Honkanen, J Mustonen, H Kainulainen, J Myllymaki, P Collin, M Hurme, I Rantala |
Kidney International | 2005 |
Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy
LX Xu, MH Zhao |
Kidney International | 2005 |
Mucosal Immunology
WR Brown |
Mucosal Immunology | 2005 |
Determination of Aberrant O- Glycosylation in the IgA1 Hinge Region by Electron Capture Dissociation Fourier Transform-Ion Cyclotron Resonance Mass Spectrometry
MB Renfrow, HJ Cooper, M Tomana, R Kulhavy, Y Hiki, K Toma, MR Emmett, J Mestecky, AG Marshall, J Novak |
The Journal of biological chemistry | 2005 |
FcγRIIa-131R allele and FcγRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy
Y Tanaka, Y Suzuki, T Tsuge, Y Kanamaru, S Horikoshi, RC Monteiro, Y Tomino |
Nephrology Dialysis Transplantation | 2005 |
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic mice
R Marquina, MA Díez, M López-Hoyos, L Buelta, A Kuroki, S Kikuchi, J Villegas, M Pihlgren, CA Siegrist, M Arias, S Izui, J Merino, R Merino |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
Detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients by using synthetic hinge peptide and glycopeptide probes*
I Nakamura, H Iwase, K Arai, Y Nagai, K Toma, T Katsumata, Y Hiki, T Kokubo, T Sano, Y Kobayashi |
Nephrology | 2004 |
Use of corticosteroids, other immunosuppressive therapies, and tonsillectomy in the treatment of IgA nephropathy
O Hotta |
Seminars in Nephrology | 2004 |
Aberrant glycosylation in IgA nephropathy (IgAN)
R Coppo, A Amore |
Kidney International | 2004 |
Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy
A Koyama, S Sharmin, H Sakurai, Y Shimizu, K Hirayama, J Usui, M Nagata, K Yoh, K Yamagata, K Muro, M Kobayashi, K Ohtani, T Shimizu, T Shimizu |
Kidney International | 2004 |
An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy
PJ van der Boog, C Kooten, A Seggelen, M Mallat, N Klar-Mohamad, JW de Fijter, MR Daha |
Nephrology Dialysis Transplantation | 2004 |
Is IgA nephropathy induced by hyperproduction of interferon-α?
EN Wardle |
Medical Hypotheses | 2004 |
IgA nephropathy: an update:
BA Julian, J Novak |
Current Opinion in Nephrology and Hypertension | 2004 |
Development of IgA nephritis following cat scratch disease in a 13-year-old boy
L Hopp, SC Eppes |
Pediatric Nephrology | 2004 |
IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy
A Horie, Y Hiki, H Odani, Y Yasuda, M Takahashi, M Kato, H Iwase, Y Kobayashi, I Nakashima, K Maeda |
American Journal of Kidney Diseases | 2003 |
Complexes of IgA with FcαRI/CD89 are not specific for primary IgA nephropathy
PJ van der Boog, JW de Fijter, C Kooten, R der Holst, A Seggelen, LA van Es, MR Daha |
Kidney International | 2003 |
Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schönlein nephritis: association between CD71 expression and IgA deposits
E Haddad, IC Moura, M Arcos-Fajardo, MA Macher, V Baudouin, C Alberti, C Loirat, RC Monteiro, M Peuchmaur |
Journal of the American Society of Nephrology : JASN | 2003 |
Henoch-Schonlein purpura nephritis
FC Fervenza |
International Journal of Dermatology | 2003 |
Pathogénie de la maladie de Berger : implication des immunoglobulines A et de leurs récepteurs
RC Monteiro, V Leroy, P Launay, IC Moura, M Arcos-Fajardo, M Benhamou, É Haddad |
médecine/sciences | 2003 |
Interactions of human mesangial cells with IgA and IgA-containing immune complexes1
J Novak, HL Vu, L Novak, BA Julian, J Mestecky, M Tomana |
Kidney International | 2002 |
Pathogenic significance of IgA receptor interactions in IgA nephropathy
RC Monteiro, IC Moura, P Launay, T Tsuge, E Haddad, M Benhamou, MD Cooper, M Arcos-Fajardo |
Trends in Molecular Medicine | 2002 |
Pathogenic potential of galactose-deficient IgA1 in IgA nephropathy
J MESTECKY, J NOVAK, BA JULIAN, M TOMANA |
Nephrology | 2002 |
IgA-Nephropathie
J Floege, HJ Grne |
Der Internist | 2002 |
Identification of the Transferrin Receptor as a Novel Immunoglobulin (Ig)a1 Receptor and Its Enhanced Expression on Mesangial Cells in Iga Nephropathy
IC Moura, MN Centelles, M Arcos-Fajardo, DM Malheiros, JF Collawn, MD Cooper, RC Monteiro |
Journal of Experimental Medicine | 2001 |
Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy
Y Hiki, H Odani, M Takahashi, Y Yasuda, A Nishimoto, H Iwase, T Shinzato, Y Kobayashi, K Maeda |
Kidney International | 2001 |
T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation
SR Chintalacharuvu, NU Nagy, N Sigmund, JG Nedrud, ME Amm, SN Emancipator |
Clinical & Experimental Immunology | 2001 |
Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy
IC Moura, MN Centelles, M Arcos-Fajardo, DM Malheiros, JF Collawn, MD Cooper, RC Monteiro |
Journal of Experimental Medicine | 2001 |
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients
AC Allen, EM Bailey, PE Brenchley, KS Buck, J Barratt, J Feehally |
Kidney International | 2001 |
Chemoenzymatic Synthesis of Biotinylated Nucleotide Sugars as Substrates for Glycosyltransferases
T Bülter, T Schumacher, DJ Namdjou, RG Gallego, H Clausen, L Elling |
ChemBioChem | 2001 |
Henoch-Sch??nlein purpura
FT Saulsbury |
Current Opinion in Rheumatology | 2001 |
Hypersialylated macromolecular serum immunoglobulin A1 in type 2 diabetes mellitus
L Vázquez–Moreno, MC Candia–Plata, MR Robles–Burgueño |
Clinical Biochemistry | 2001 |
Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells
A Amore, P Cirina, G Conti, P Brusa, L Peruzzi, R Coppo |
Journal of the American Society of Nephrology : JASN | 2001 |
Severe non‐proliferative lupus nephritis with predominant sub‐endothelial IgA deposits
S Florquin, A Roos, JW Groothoff, N Claessen, DJ van GijlswijkJanssen, J Aten, JC Davin, JJ Weening |
Nephrology Dialysis Transplantation | 2001 |
Progress in molecular and genetic studies of IgA nephropathy
J Novak, B A Julian, M Tomana, J Mesteck |
Journal of Clinical Immunology | 2001 |
Evidence for genetic factors in the development and progression of IgA nephropathy
SI Hsu, SB Ramirez, MP Winn, JV Bonventre, WF Owen |
Kidney International | 2000 |
Heterogeneity of O-glycosylation in the hinge region of human IgA1
J Novak, M Tomana, M Kilian, L Coward, R Kulhavy, S Barnes, J Mestecky |
Molecular Immunology | 2000 |
The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes
A Rifai, K Fadden, SL Morrison, KR Chintalacharuvu |
Journal of Experimental Medicine | 2000 |
Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice
P Launay, B Grossetête, M Arcos-Fajardo, E Gaudin, SP Torres, L Beaudoin, NP de Serre, A Lehuen, RC Monteiro |
Journal of Experimental Medicine | 2000 |
Authors' reply:
Y Hisada, T Sugaya |
American Journal of Kidney Diseases | 2000 |
Fc Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease): Evidence for Pathogenic Soluble Receptor-Iga Complexes in Patients and Cd89 Transgenic Mice
P Launay, B Grossetete, M Arcos-Fajardo, E Gaudin, SP Torres, L Beaudoin, NP de Serre, A Lehuen, RC Monteiro |
Journal of Experimental Medicine | 2000 |
The N-Glycans Determine the Differential Blood Clearance and Hepatic Uptake of Human Immunoglobulin (Ig)a1 and Iga2 Isotypes
A Rifai, K Fadden, SL Morrison, KR Chintalacharuvu |
Journal of Experimental Medicine | 2000 |
IgA myeloma presenting as Henoch-Schönlein purpura with nephritis
AM Zickerman, AC Allen, V Talwar, SA Olczak, A Brownlee, M Holland, PN Furness, NJ Brunskill, J Feehally |
American journal of kidney diseases : the official journal of the National Kidney Foundation | 2000 |
IgA1 glycosylation and the pathogenesis of IgA nephropathy
AC Allen, J Feehally |
American journal of kidney diseases : the official journal of the National Kidney Foundation | 2000 |
IgA Nephropathy: Recent Developments
J Floege, J Feehally |
Journal of the American Society of Nephrology : JASN | 2000 |
IgA nephropathy
TE Hunley, V Kon |
Current Opinion in Pediatrics | 1999 |
Pathogenesis of IgA nephropathy
LA ES, JW FIJTER, M Daha |
Nephrology | 1997 |
Rheumatology
RA Asherson, R Cervera, DP D'Cruz, GR Hughes |
Postgraduate medical journal | 1991 |
Autoantibodies
MH Lessof, SP Asper |
American Heart Journal | 1960 |